LLY

1,054.27

-0.65%↓

JNJ

209.54

-2.29%↓

ABBV

223.9

-1.64%↓

UNH

334.13

-2.12%↓

AZN

91.41

-0.2%↓

LLY

1,054.27

-0.65%↓

JNJ

209.54

-2.29%↓

ABBV

223.9

-1.64%↓

UNH

334.13

-2.12%↓

AZN

91.41

-0.2%↓

LLY

1,054.27

-0.65%↓

JNJ

209.54

-2.29%↓

ABBV

223.9

-1.64%↓

UNH

334.13

-2.12%↓

AZN

91.41

-0.2%↓

LLY

1,054.27

-0.65%↓

JNJ

209.54

-2.29%↓

ABBV

223.9

-1.64%↓

UNH

334.13

-2.12%↓

AZN

91.41

-0.2%↓

LLY

1,054.27

-0.65%↓

JNJ

209.54

-2.29%↓

ABBV

223.9

-1.64%↓

UNH

334.13

-2.12%↓

AZN

91.41

-0.2%↓

Search

Odonate Therapeutics Inc

Închisă

0

Rezumat

Modificarea prețului

24h

Curent

Minim

Maxim

Indicatori cheie

By Trading Economics

Odonate Therapeutics Inc Grafic

Performanțele din trecut nu reprezintă un indicator fiabil al rezultatelor viitoare.

Știri relevante

16 dec. 2025, 23:46 UTC

Market Talk

Gold Edges Higher, Aided by Fed Rate-Cut Prospects -- Market Talk

16 dec. 2025, 23:38 UTC

Market Talk

Nikkei May Rise on Possible Bargain-Hunting Interest -- Market Talk

16 dec. 2025, 22:35 UTC

Achiziții, Fuziuni, Preluări

Santos: Sale Delivered Cash, Reduced Future Decommissioning Exposure

16 dec. 2025, 22:35 UTC

Achiziții, Fuziuni, Preluări

Santos Sold 43% Stake in Petrel Fields, 100% of Tern Fields to Eni Australia

16 dec. 2025, 22:33 UTC

Achiziții, Fuziuni, Preluări

Santos: A$40M Upfront Consideration, Up to A$20M in Contingent Payments

16 dec. 2025, 22:33 UTC

Achiziții, Fuziuni, Preluări

Santos Sold 43% Operated Interest in Mahalo JV to Comet Ridge

16 dec. 2025, 22:32 UTC

Achiziții, Fuziuni, Preluări

Santos Divests Two Noncore Assets as Part of Portfolio Optimization

16 dec. 2025, 22:25 UTC

Achiziții, Fuziuni, Preluări

Westgold's Indicative Timetable Points to Early February Completion

16 dec. 2025, 22:24 UTC

Achiziții, Fuziuni, Preluări

Westgold: Divestment Aligns With Broader Corporate Strategy

16 dec. 2025, 22:23 UTC

Achiziții, Fuziuni, Preluări

Westgold: Deferred Payment Based on Performance Hurdles

16 dec. 2025, 22:23 UTC

Achiziții, Fuziuni, Preluări

Westgold Will Receive A$15M Cash, A$19.6M in Alicanto Shares

16 dec. 2025, 22:23 UTC

Achiziții, Fuziuni, Preluări

Westgold to Receive A$30M Deferred Payment in Cash or Shares

16 dec. 2025, 22:22 UTC

Achiziții, Fuziuni, Preluări

Westgold Divesting Noncore Operating Asset for A$64.6M

16 dec. 2025, 22:22 UTC

Achiziții, Fuziuni, Preluări

Westgold Agrees to Sell Mt Henry-Selene Project to Alicanto Minerals

16 dec. 2025, 21:53 UTC

Câștiguri

Lennar Misses Earnings Estimates. The Stock Is Dropping. -- Barrons.com

16 dec. 2025, 21:50 UTC

Market Talk

Tech, Media & Telecom Roundup: Market Talk

16 dec. 2025, 21:33 UTC

Achiziții, Fuziuni, Preluări

Warner Preparing to Tell Shareholders to Reject Paramount Offer -- 2nd Update

16 dec. 2025, 21:18 UTC

Achiziții, Fuziuni, Preluări

Warner Preparing to Tell Shareholders to Reject Paramount Offer -- Update

16 dec. 2025, 21:17 UTC

Achiziții, Fuziuni, Preluări

Worthington Enterprises to Buy LSI Group for About $205M >WOR

16 dec. 2025, 21:16 UTC

Câștiguri

Worthington Enterprises 2Q Sales $327.5M >WOR

16 dec. 2025, 21:16 UTC

Câștiguri

Worthington Enterprises 2Q Adj EPS 65c >WOR

16 dec. 2025, 21:16 UTC

Câștiguri

Worthington Enterprises 2Q EPS 55c >WOR

16 dec. 2025, 21:15 UTC

Achiziții, Fuziuni, Preluări

Worthington Enterprises Agrees To Acquire Leading Metal Roof Components Manufacturer LSI Group >WOR

16 dec. 2025, 21:05 UTC

Achiziții, Fuziuni, Preluări

Ecolab Closes Acquisition Of Ovivo's Electronics Ultrapure Water Business >ECL

16 dec. 2025, 20:54 UTC

Achiziții, Fuziuni, Preluări

Warner to Reject Paramount Offer As Soon As Wednesday, Sources Say -- WSJ

16 dec. 2025, 20:54 UTC

Achiziții, Fuziuni, Preluări

Warner Preparing to Tell Shareholders to Reject Paramount Offer -- WSJ

16 dec. 2025, 20:54 UTC

Achiziții, Fuziuni, Preluări

Warner to Recommend Existing Netflix Deal, Sources Say -- WSJ

16 dec. 2025, 20:44 UTC

Market Talk

Russia-Ukraine Peace Efforts Send Crude to Near 5-Year Low -- Market Talk

16 dec. 2025, 20:04 UTC

Market Talk

U.S. Natural Gas Extends Weather-Driven Losing Streak -- Market Talk

16 dec. 2025, 20:01 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

Comparație

Modificare preț

Odonate Therapeutics Inc Așteptări

Date financiare

Cheltuieli de vânzare și administrare

Cheltuieli de exploatare

Profit pre-impozitare

Vânzări

Costul vânzărilor

Profit brut din vânzări

EBITDA

Profit operațional

$

Despre Odonate Therapeutics Inc

Odonate, Inc., a pharmaceutical company, develops therapeutics for the treatment of cancer. It is developing tesetaxel, an orally administered chemotherapy agent, which is in Phase III clinical study for patients with metastatic breast cancer. The company was formerly known as Odonate Therapeutics, Inc. and changed its name to Odonate, Inc. in March 2023. The company was founded in 2013 and is based in New York, New York.
help-icon Live chat